fever with low blood cell (neutrophil) count

Phase 1

Not yet recruiting

• Conditions: Health Condition 1: C00-D49- Neoplasms

• Registration Number: CTRI/2024/02/062824
• Lead Sponsor: Anjali

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 4 March 2024

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Aged 15 or above

2. Diagnosed with selected cancer and receiving chemotherapy

3. Able to speak and understand Hindi or Odia

4. Patients who are due for at least 4 months of chemotherapy

Exclusion Criteria

1. In-patient

2. Visual or hearing impaired;

3. Known cognitive impairment;

4. Known psychiatric illness,

5. Eastern Cooperative Oncology Group (ECOG) performance status score greater than two.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence Febrile NeutropeniaTimepoint: After 14/21 days (In 1st , 2nd and 3rd follow-up)

Secondary Outcome Measures

Name	Time	Method
Knowledge, Self-care practice and Hand-wash competencyTimepoint: 3rd follow-up or After the 2 months of intervention